According to PetIQ's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.534848. At the end of 2023 the company had a P/S ratio of 0.5274.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.5274 | 75.75% |
2022 | 0.3001 | -57.71% |
2021 | 0.7095 | -44.01% |
2020 | 1.27 | 52.38% |
2019 | 0.8317 | -13.36% |
2018 | 0.9599 | -11.35% |
2017 | 1.08 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 1.05 | 96.19% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 92.5 | 17,194.37% | ๐บ๐ธ USA |